Comparative evaluation of the effectiveness of spirinolactone and eplerenone in patients with different left ventricular ejection fraction in chronic heart failure.

Abstract

In the article, the scientific literature confirming the effect of spirinolactone and eplerenone, belonging to the group of mineralocorticoid receptor antagonists, on the quality of life, the number of hospitalizations, the outcome of the disease, and the length of life of patients with chronic heart failure was studied, and the effects of these two drugs were comparatively evaluated.